{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:56:00Z","timestamp":1792598160293,"version":"4.5.0"},"reference-count":74,"publisher":"MyJove Corporation","issue":"218","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68023","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:00:48Z","timestamp":1745607648000},"source":"Crossref","is-referenced-by-count":0,"title":["Construction of Lung Adenocarcinoma Xenograft Model in Mice and Evaluation of the Efficiency of XY Decoction through MAPK Pathway"],"prefix":"10.3791","author":[{"given":"Yuhan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongcai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","type":"journal-article","article-title":"Cancer statistics for the year 2020: An overview","volume":"149","author":"Ferlay","year":"2021","unstructured":"Ferlay, J. et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 149 (4), 778-789 (2021).","journal-title":"Int J Cancer"},{"issue":"3","key":"ref2","first-page":"209","type":"journal-article","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71 (3), 209-249 (2021).","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cllc.2022.07.012","type":"journal-article","article-title":"Asian Thoracic Oncology Research Group (ATORG) expert consensus statement on MET alterations in NSCLC: Diagnostic and therapeutic considerations","volume":"23","author":"Ahn","year":"2022","unstructured":"Ahn, M. J. et al. Asian Thoracic Oncology Research Group (ATORG) expert consensus statement on MET alterations in NSCLC: Diagnostic and therapeutic considerations. Clin Lung Cancer. 23 (8), 670-685 (2022).","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/cancers14071759","type":"journal-article","article-title":"Lung adenocarcinoma tumor origin: A guide for personalized medicine","volume":"14","author":"Seguin","year":"2022","unstructured":"Seguin, L., Durandy, M., Feral, C. C. Lung adenocarcinoma tumor origin: A guide for personalized medicine. Cancers (Basel). 14 (7), 1759 (2022).","journal-title":"Cancers (Basel)"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.mcna.2018.12.006","type":"journal-article","article-title":"Lung cancer","volume":"103","author":"Nasim","year":"2019","unstructured":"Nasim, F., Sabath, B. F., Eapen, G. A. Lung cancer. Med Clin North Am. 103(3), 463-473 (2019).","journal-title":"Med Clin North Am"},{"issue":"5","key":"ref6","first-page":"409","type":"journal-article","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","unstructured":"Miller, K. D. et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin., 72 (5), 409-436 (2022).","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 4","key":"ref7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7861\/clinmed.22-4-s38","type":"journal-article","article-title":"Understanding prognosis and survival outcomes in patients with early-stage non-small-cell lung cancer","volume":"22","author":"Torrente","year":"2022","unstructured":"Torrente, M. et al. Understanding prognosis and survival outcomes in patients with early-stage non-small-cell lung cancer. Clin Med (Lond). 22 (Suppl 4), 38-40 (2022).","journal-title":"Clin Med (Lond)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"111381","DOI":"10.1016\/j.biopha.2021.111381","type":"journal-article","article-title":"Traditional Chinese medicine and lung cancer--From theory to practice","volume":"137","author":"Li","year":"2021","unstructured":"Li, Z., Feiyue, Z., Gaofeng, L. Traditional Chinese medicine and lung cancer--From theory to practice. Biomed Pharmacother. 137, 111381 (2021).","journal-title":"Biomed Pharmacother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"115748","DOI":"10.1016\/j.jep.2022.115748","type":"journal-article","article-title":"Traditional Chinese medicine has great potential as candidate drugs for lung cancer: A review","volume":"300","author":"Wei","year":"2023","unstructured":"Wei, Z. et al. Traditional Chinese medicine has great potential as candidate drugs for lung cancer: A review. J Ethnopharmacol. 300, 115748 (2023).","journal-title":"J Ethnopharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1277243","DOI":"10.3389\/fimmu.2023.1277243","type":"journal-article","article-title":"Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy","volume":"14","author":"Miao","year":"2023","unstructured":"Miao, K. et al. Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy. Front Immunol. 14, 1277243 (2023).","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"111044","DOI":"10.1016\/j.biopha.2020.111044","type":"journal-article","article-title":"Anticancer activities of TCM and their active components against tumor metastasis","volume":"133","author":"Wang","year":"2021","unstructured":"Wang, K. et al. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother. 133, 111044 (2021).","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s00432-020-03353-0","type":"journal-article","article-title":"Efficacy and safety of TCM combined with chemotherapy for SCLC: A systematic review and meta-analysis","volume":"146","author":"Chen","year":"2020","unstructured":"Chen, S. et al. Efficacy and safety of TCM combined with chemotherapy for SCLC: A systematic review and meta-analysis. J Cancer Res Clin Oncol. 146 (11), 2913-2935 (2020).","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.apsb.2021.02.017","type":"journal-article","article-title":"Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography-mass spectrometry","volume":"11","author":"Yu","year":"2021","unstructured":"Yu, Y., Yao, C., Guo, D. A. Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography-mass spectrometry. Acta Pharm Sin B. 11 (6), 1469-1492 (2021).","journal-title":"Acta Pharm Sin B"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"869972","DOI":"10.3389\/fchem.2022.869972","type":"journal-article","article-title":"Integrated serum pharmacochemistry and network pharmacology approach to explore the effective components and potential mechanisms of Menispermi rhizoma against myocardial ischemia","volume":"10","author":"Wei","year":"2022","unstructured":"Wei, J. et al. Integrated serum pharmacochemistry and network pharmacology approach to explore the effective components and potential mechanisms of Menispermi rhizoma against myocardial ischemia. Front Chem. 10, 869972 (2022).","journal-title":"Front Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"154177","DOI":"10.1016\/j.phymed.2022.154177","type":"journal-article","article-title":"Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology","volume":"102","author":"Shao","year":"2022","unstructured":"Shao, D. et al. Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology. Phytomedicine. 102, 154177 (2022).","journal-title":"Phytomedicine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8895950","DOI":"10.1155\/2022\/8895950","type":"journal-article","article-title":"Using network pharmacology to explore the mechanism of panax notoginseng in the treatment of myocardial fibrosis","volume":"2022","author":"Han","year":"2022","unstructured":"Han, J. et al. Using network pharmacology to explore the mechanism of panax notoginseng in the treatment of myocardial fibrosis. J Diabetes Res. 2022, 8895950 (2022).","journal-title":"J Diabetes Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"105454","DOI":"10.1016\/j.compbiomed.2022.105454","type":"journal-article","article-title":"Mechanisms underlying the therapeutic effects of Qingfeiyin in treating acute lung injury based on GEO datasets, network pharmacology and molecular docking","volume":"145","author":"Wang","year":"2022","unstructured":"Wang, Y. et al. Mechanisms underlying the therapeutic effects of Qingfeiyin in treating acute lung injury based on GEO datasets, network pharmacology and molecular docking. Comput Biol Med. 145, 105454 (2022).","journal-title":"Comput Biol Med"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.7150\/thno.79493","type":"journal-article","article-title":"Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small-cell lung cancer","volume":"13","author":"Rubio","year":"2023","unstructured":"Rubio, K. et al. Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small-cell lung cancer. Theranostics. 13 (8), 2384-2407 (2023).","journal-title":"Theranostics"},{"issue":"2","key":"ref19","first-page":"112","type":"journal-article","article-title":"Animal welfare and slaughter methods of fur animal","volume":"15","author":"Guo","year":"2011","unstructured":"Guo, T. F., Li, W., Xi, B. Animal welfare and slaughter methods of fur animal. J Econ Anim. 15 (2), 112-119 (2011).","journal-title":"J Econ Anim"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.62347\/RYSQ1416","type":"journal-article","article-title":"Synergistic anticancer activity of resveratrol with cisplatin and carboplatin in A549 lung adenocarcinoma cells","volume":"17","author":"Moar","year":"2024","unstructured":"Moar, K. et al. Synergistic anticancer activity of resveratrol with cisplatin and carboplatin in A549 lung adenocarcinoma cells. Int J Clin Exp Pathol. 17 (11), 411-420 (2024).","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"ref21","first-page":"529","type":"journal-article","article-title":"Exploring tumor-suppressive effect and mechanism of action of Zilongjin Tablets combined with icotinib in Lewis tumor-bearing mice based on EGFR\/PI3K\/Akt signaling pathway","volume":"56","author":"Li","year":"2025","unstructured":"Li, Z. et al. Exploring tumor-suppressive effect and mechanism of action of Zilongjin Tablets combined with icotinib in Lewis tumor-bearing mice based on EGFR\/PI3K\/Akt signaling pathway. Chin Tradit Herb Drugs. 56 (2), 529-535 (2025).","journal-title":"Chin Tradit Herb Drugs"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/d41573-020-00202-0","type":"journal-article","article-title":"Addressing cancer's grand challenges","volume":"19","author":"Mullard","year":"2020","unstructured":"Mullard, A. Addressing cancer's grand challenges. Nat Rev Drug Discov. 19 (12), 825-826 (2020).","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1158\/1055-9965.EPI-22-0542","type":"journal-article","article-title":"AACR cancer disparities progress report 2022","volume":"31","author":"Williams","year":"2022","unstructured":"Williams, P. A., Zaidi, S. K., Sengupta, R. AACR cancer disparities progress report 2022. Cancer Epidemiol Biomarkers Prev. 31 (7), 1249-50 (2022).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Pt A","key":"ref24","doi-asserted-by":"crossref","first-page":"116948","DOI":"10.1016\/j.jep.2023.116948","type":"journal-article","article-title":"Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4\/MyD88\/NF-\u03baB pathway","volume":"318","author":"Zhao","year":"2024","unstructured":"Zhao, W. et al. Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4\/MyD88\/NF-\u03baB pathway. J Ethnopharmacol. 318 (Pt A), 116948 (2024).","journal-title":"J Ethnopharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2147\/DDDT.S414098","type":"journal-article","article-title":"Integrating network pharmacology and experimental validation to explore the effects and mechanisms of Qinghao Biejia decoction and its active compound artemisinin B against non-small-cell lung cancer","volume":"17","author":"Ye","year":"2023","unstructured":"Ye, Y. et al. Integrating network pharmacology and experimental validation to explore the effects and mechanisms of Qinghao Biejia decoction and its active compound artemisinin B against non-small-cell lung cancer. Drug Des Devel Ther. 17, 2461-2479 (2023).","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jtcme.2023.03.008","type":"journal-article","article-title":"Ze-Qi decoction inhibits non-small cell lung cancer growth and metastasis by modulating the PI3K\/Akt\/p53 signaling pathway","volume":"13","author":"Zhang","year":"2023","unstructured":"Zhang, J. et al. Ze-Qi decoction inhibits non-small cell lung cancer growth and metastasis by modulating the PI3K\/Akt\/p53 signaling pathway. J Tradit Complement Med. 13 (5), 417-429 (2023).","journal-title":"J Tradit Complement Med"},{"issue":"Pt 3","key":"ref27","doi-asserted-by":"crossref","first-page":"119127","DOI":"10.1016\/j.jep.2024.119127","type":"journal-article","article-title":"Maimendong decoction inhibits lung cancer metastasis by increasing the proportion and killing activity of NK cells","volume":"338","author":"Zhang","year":"2025","unstructured":"Zhang, Z. et al. Maimendong decoction inhibits lung cancer metastasis by increasing the proportion and killing activity of NK cells. J Ethnopharmacol. 338 (Pt 3), 119127(2025).","journal-title":"J Ethnopharmacol"},{"issue":"Pt A","key":"ref28","doi-asserted-by":"crossref","first-page":"106293","DOI":"10.1016\/j.compbiomed.2022.106293","type":"journal-article","article-title":"Explore the mechanism and substance basis of Mahuang FuziXixin decoction for the treatment of lung cancer based on network pharmacology and molecular docking","volume":"151","author":"Zhang","year":"2022","unstructured":"Zhang, W. et al. Explore the mechanism and substance basis of Mahuang FuziXixin decoction for the treatment of lung cancer based on network pharmacology and molecular docking. Comput Biol Med. 151 (Pt A), 106293 (2022).","journal-title":"Comput Biol Med"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4062\/biomolther.2022.113","type":"journal-article","article-title":"Picropodophyllotoxin inhibits cell growth and induces apoptosis in gefitinib-resistant non-small lung cancer cells by dual-targeting EGFR and MET","volume":"31","author":"Lee","year":"2023","unstructured":"Lee, J. Y. et al. Picropodophyllotoxin inhibits cell growth and induces apoptosis in gefitinib-resistant non-small lung cancer cells by dual-targeting EGFR and MET. Biomol Ther (Seoul). 31 (2), 200-209 (2023).","journal-title":"Biomol Ther (Seoul)"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"105574","DOI":"10.1016\/j.phrs.2021.105574","type":"journal-article","article-title":"Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anticancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling","volume":"171","author":"Li","year":"2021","unstructured":"Li, J. X. et al. Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anticancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling. Pharmacol Res. 171, 105574 (2021).","journal-title":"Pharmacol Res"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jgr.2021.11.004","type":"journal-article","article-title":"Ginsenoside Rg1 suppresses cancer cell proliferation through perturbing mitotic progression","volume":"46","author":"Hong","year":"2022","unstructured":"Hong, J., Gwon, D., Jang, C. Y. Ginsenoside Rg1 suppresses cancer cell proliferation through perturbing mitotic progression. J Ginseng Res. 46 (3), 481-488 (2022).","journal-title":"J Ginseng Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"113305","DOI":"10.1016\/j.jep.2020.113305","type":"journal-article","article-title":"Shuangshen granules attenuate lung metastasis by modulating bone marrow differentiation through mTOR signaling inhibition","volume":"281","author":"Wei","year":"2021","unstructured":"Wei, H. et al. Shuangshen granules attenuate lung metastasis by modulating bone marrow differentiation through mTOR signaling inhibition. J Ethnopharmacol. 281, 113305 (2021).","journal-title":"J Ethnopharmacol"},{"issue":"21","key":"ref33","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.3390\/molecules25214905","type":"journal-article","article-title":"Anti-Angiogenic properties of Ginsenoside Rg3","volume":"25","author":"Nakhjavani","year":"2020","unstructured":"Nakhjavani, M. et al. Anti-Angiogenic properties of Ginsenoside Rg3. Molecules. 25 (21), 4905 (2020).","journal-title":"Molecules"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s11033-021-06187-2","type":"journal-article","article-title":"Insights into the antitumor mechanism of ginsenosides Rg3","volume":"48","author":"Liu","year":"2021","unstructured":"Liu, Z. et al. Insights into the antitumor mechanism of ginsenosides Rg3. Mol Biol Rep. 48 (3), 2639-2652 (2021).","journal-title":"Mol Biol Rep"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1039\/C4FO01017E","type":"journal-article","article-title":"Stachyose-induced apoptosis of Caco-2 cells via the caspase-dependent mitochondrial pathway","volume":"6","author":"Huang","year":"2015","unstructured":"Huang, G. et al. Stachyose-induced apoptosis of Caco-2 cells via the caspase-dependent mitochondrial pathway. Food Funct. 6 (3),765-771 (2015).","journal-title":"Food Funct"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"112283","DOI":"10.1016\/j.jep.2019.112283","type":"journal-article","article-title":"Mechanistic and therapeutic study of novel antitumor function of natural compound imperialine for treating non-small cell lung cancer","volume":"247","author":"Lin","year":"2020","unstructured":"Lin, Q. et al. Mechanistic and therapeutic study of novel antitumor function of natural compound imperialine for treating non-small cell lung cancer. J Ethnopharmacol. 247, 112283 (2020).","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/ddr.21987","type":"journal-article","article-title":"Peimine-induced apoptosis and inhibition of migration by regulating reactive oxygen species-mediated MAPK\/STAT3\/NF-\u03baB and Wnt\/\u03b2-catenin signaling pathways in gastric cancer MKN-45 cells","volume":"83","author":"Zhang","year":"2022","unstructured":"Zhang, T. et al. Peimine-induced apoptosis and inhibition of migration by regulating reactive oxygen species-mediated MAPK\/STAT3\/NF-\u03baB and Wnt\/\u03b2-catenin signaling pathways in gastric cancer MKN-45 cells. Drug Dev Res. 83 (7), 1683-1696 (2022).","journal-title":"Drug Dev Res"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1871520622666220324100510","type":"journal-article","article-title":"Peimine inhibits MCF-7 breast cancer cell growth by modulating inflammasome activation: Critical roles of MAPK and NF-\u03baB signaling","volume":"23","author":"Sun","year":"2023","unstructured":"Sun, J. et al. Peimine inhibits MCF-7 breast cancer cell growth by modulating inflammasome activation: Critical roles of MAPK and NF-\u03baB signaling. Anticancer Agents Med Chem. 23 (3), 317-327 (2023).","journal-title":"Anticancer Agents Med Chem"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"e17072","DOI":"10.1016\/j.heliyon.2023.e17072","type":"journal-article","article-title":"Jujuboside B suppresses angiogenesis and tumor growth via blocking VEGFR2 signaling pathway","volume":"9","author":"Zhang","year":"2023","unstructured":"Zhang, P. et al. Jujuboside B suppresses angiogenesis and tumor growth via blocking VEGFR2 signaling pathway. Heliyon. 9 (6), e17072 (2023).","journal-title":"Heliyon"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"668887","DOI":"10.3389\/fphar.2021.668887","type":"journal-article","article-title":"Jujuboside B inhibits the proliferation of breast cancer cell lines by inducing apoptosis and autophagy","volume":"12","author":"Guo","year":"2021","unstructured":"Guo, L. et al. Jujuboside B inhibits the proliferation of breast cancer cell lines by inducing apoptosis and autophagy. Front Pharmacol. 12, 668887 (2021).","journal-title":"Front Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4534411","DOI":"10.1155\/2022\/4534411","type":"journal-article","article-title":"Aucubin exerts anticancer activity in breast cancer and regulates intestinal microbiota","volume":"2022","author":"Shao","year":"2022","unstructured":"Shao, M. et al. Aucubin exerts anticancer activity in breast cancer and regulates intestinal microbiota. Evid Based Complement Alternat Med. 2022, 4534411 (2022).","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5211368","DOI":"10.1155\/2022\/5211368","type":"journal-article","article-title":"Jujuboside B reverses CUMS-promoted tumor progression via blocking PI3K\/Akt and MAPK\/ERK and dephosphorylating CREB signaling","volume":"2022","author":"Yang","year":"2022","unstructured":"Yang, Z. et al. Jujuboside B reverses CUMS-promoted tumor progression via blocking PI3K\/Akt and MAPK\/ERK and dephosphorylating CREB signaling. J Immunol Res. 2022, 5211368 (2022).","journal-title":"J Immunol Res"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1871520622666220324100510","type":"journal-article","article-title":"Peimine inhibits MCF-7 breast cancer cell growth by modulating inflammasome activation: Critical roles of MAPK and NF-\u03baB signaling","volume":"23","author":"Sun","year":"2023","unstructured":"Sun, J. et al. Peimine inhibits MCF-7 breast cancer cell growth by modulating inflammasome activation: Critical roles of MAPK and NF-\u03baB signaling. Anticancer Agents Med Chem. 23 (3), 317-327 (2023).","journal-title":"Anticancer Agents Med Chem"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3892\/ijo.2015.2886","type":"journal-article","article-title":"Ginsenoside Rg3-induced EGFR\/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4\/LeY expression","volume":"46","author":"Shan","year":"2015","unstructured":"Shan, X. et al. Ginsenoside Rg3-induced EGFR\/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4\/LeY expression. Int J Oncol. 46 (4), 1667-1676 (2015).","journal-title":"Int J Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"114392","DOI":"10.1016\/j.colsurfb.2024.114392","type":"journal-article","article-title":"Low toxicity ginsenoside Rg1-carbon nanodots as a potential therapeutic agent for human non-small cell lung cancer","volume":"246","author":"Wang","year":"2025","unstructured":"Wang, J. et al. Low toxicity ginsenoside Rg1-carbon nanodots as a potential therapeutic agent for human non-small cell lung cancer. Colloids Surf B Biointerfaces. 246, 114392 (2025).","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2147\/OTT.S361512","type":"journal-article","article-title":"Aberrant MAPK signaling offers therapeutic potential for treatment of ovarian carcinoma","volume":"15","author":"Colic","year":"2022","unstructured":"Colic, E., Patel, P. U., Kent, O. A. Aberrant MAPK signaling offers therapeutic potential for treatment of ovarian carcinoma. Onco Targets Ther. 15, 1331-1346 (2022).","journal-title":"Onco Targets Ther"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","type":"journal-article","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: From mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","unstructured":"Bahar, M. E., Kim, H. J., Kim, D. R. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: From mechanism to clinical studies. Signal Transduct Target Ther. 8 (1), 455 (2023).","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/cells10102509","type":"journal-article","article-title":"ERK: A double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer","volume":"10","author":"Sugiura","year":"2021","unstructured":"Sugiura, R., Satoh, R., Takasaki, T. ERK: A double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells. 10 (10), 2509 (2021).","journal-title":"Cells"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","type":"journal-article","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","unstructured":"Ullah, R. et al. RAF-MEK-ERK pathway in cancer evolution and treatment. Semin Cancer Biol. 85, 123-154 (2022).","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1021\/acs.jcim.3c00014","type":"journal-article","article-title":"Analysis of the ERK pathway cysteinome for targeted covalent inhibition of RAF and MEK kinases","volume":"63","author":"Romany","year":"2023","unstructured":"Romany, A. et al. Analysis of the ERK pathway cysteinome for targeted covalent inhibition of RAF and MEK kinases. J Chem Inf Model. 63 (8), 2483-2494 (2023).","journal-title":"J Chem Inf Model"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/cmdc.201900107","type":"journal-article","article-title":"Covalent inhibition in drug discovery","volume":"14","author":"Ghosh","year":"2019","unstructured":"Ghosh, A. K. et al. Covalent inhibition in drug discovery. ChemMedChem. 14 (9), 889-906 (2019).","journal-title":"ChemMedChem"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1038\/s41467-019-12996-8","type":"journal-article","article-title":"Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo","volume":"10","author":"Kaoud","year":"2019","unstructured":"Kaoud, T. S. et al. Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo. Nat Commun. 10 (1), 5232 (2019).","journal-title":"Nat Commun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"116198","DOI":"10.1016\/j.jep.2023.116198","type":"journal-article","article-title":"Qingyihuaji formula promotes apoptosis and autophagy through inhibition of MAPK\/ERK and PI3K\/Akt\/mTOR signaling pathway on pancreatic cancer in vivo and in vitro","volume":"307","author":"Qian","year":"2023","unstructured":"Qian, X. et al. Qingyihuaji formula promotes apoptosis and autophagy through inhibition of MAPK\/ERK and PI3K\/Akt\/mTOR signaling pathway on pancreatic cancer in vivo and in vitro. J Ethnopharmacol. 307, 116198 (2023).","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"ref54","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3390\/molecules24112165","type":"journal-article","article-title":"A ferulic acid derivative FXS-3 inhibits proliferation and metastasis of human lung cancer A549 cells via positive JNK signaling pathway and negative ERK\/p38, AKT\/mTOR and MEK\/ERK signaling pathways","volume":"24","author":"Yue","year":"2019","unstructured":"Yue, S. J. et al. A ferulic acid derivative FXS-3 inhibits proliferation and metastasis of human lung cancer A549 cells via positive JNK signaling pathway and negative ERK\/p38, AKT\/mTOR and MEK\/ERK signaling pathways. Molecules. 24 (11), 2165 (2019).","journal-title":"Molecules"},{"key":"ref55","type":"journal-article","article-title":"Piperine induces cellular stresses, apoptosis, and cytotoxicity via JNK signaling and has concentration-dependently additive or synergistic effects with sorafenib in hepatocellular carcinoma: An in vitro study","author":"Ozgun","year":"2024","unstructured":"Ozgun, G. S. et al. Piperine induces cellular stresses, apoptosis, and cytotoxicity via JNK signaling and has concentration-dependently additive or synergistic effects with sorafenib in hepatocellular carcinoma: An in vitro study. Naunyn Schmiedebergs Arch Pharmacol. (2024).","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3390\/ijms21061913","type":"journal-article","article-title":"The p38 pathway: From biology to cancer therapy","volume":"21","author":"Mart\u00ednez-Lim\u00f3n","year":"2020","unstructured":"Mart\u00ednez-Lim\u00f3n, A. et al. The p38 pathway: From biology to cancer therapy. Int J Mol Sci. 21 (6), 1913 (2020).","journal-title":"Int J Mol Sci"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3892\/ol.2016.5099","type":"journal-article","article-title":"Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549\/Taxol cells via modulation of MAPK and PI3K\/Akt signaling pathways","volume":"12","author":"Xie","year":"2016","unstructured":"Xie, C. Q. et al. Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549\/Taxol cells via modulation of MAPK and PI3K\/Akt signaling pathways. Oncol Lett. 12 (5), 3586-3590 (2016).","journal-title":"Oncol Lett"},{"issue":"3","key":"ref58","first-page":"945","type":"journal-article","article-title":"Anticancer effects of baicalein on cervical carcinoma cells through down-regulation of the ERK\/p38\/MAPK pathway","volume":"35","author":"Luo","year":"2021","unstructured":"Luo, Y. H. et al. Anticancer effects of baicalein on cervical carcinoma cells through down-regulation of the ERK\/p38\/MAPK pathway. J Biol Regul Homeost Agents. 35 (3), 945-952 (2021).","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"114073","DOI":"10.1016\/j.jep.2021.114073","type":"journal-article","article-title":"Aidi injection induces apoptosis of hepatocellular carcinoma cells through the mitochondrial pathway","volume":"274","author":"Lan","year":"2021","unstructured":"Lan, H. Y. et al. Aidi injection induces apoptosis of hepatocellular carcinoma cells through the mitochondrial pathway. J Ethnopharmacol. 274, 114073 (2021).","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"ref60","doi-asserted-by":"crossref","first-page":"210120","DOI":"10.1098\/rsob.210120","type":"journal-article","article-title":"The intrinsically disorderly story of Ki-67","volume":"11","author":"Remnant","year":"2021","unstructured":"Remnant, L. et al. The intrinsically disorderly story of Ki-67. Open Biol. 11 (8), 210120 (2021).","journal-title":"Open Biol"},{"issue":"10","key":"ref61","doi-asserted-by":"crossref","first-page":"909.e1","DOI":"10.1016\/j.crad.2018.05.027","type":"journal-article","article-title":"Breast cancer Ki67 expression prediction by DCE-MRI radiomics features","volume":"73","author":"Ma","year":"2018","unstructured":"Ma, W. et al. Breast cancer Ki67 expression prediction by DCE-MRI radiomics features. Clin Radiol. 73 (10), 909.e1-e5 (2018).","journal-title":"Clin Radiol"},{"issue":"4","key":"ref62","first-page":"955","type":"journal-article","article-title":"Proliferative index (Ki67) for prediction in breast duct carcinomas","volume":"19","author":"Ahmed","year":"2018","unstructured":"Ahmed, S. T. et al. Proliferative index (Ki67) for prediction in breast duct carcinomas. Asian Pac J Cancer Prev. 19 (4), 955-959 (2018).","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"ref63","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1158\/0008-5472.CAN-16-0707","type":"journal-article","article-title":"Cell-cycle regulation accounts for variability in Ki-67 expression levels","volume":"77","author":"Sobecki","year":"2017","unstructured":"Sobecki, M. et al. Cell-cycle regulation accounts for variability in Ki-67 expression levels. Cancer Res. 77 (10), 2722-2734 (2017).","journal-title":"Cancer Res"},{"issue":"7","key":"ref64","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/PAI.0000000000001087","type":"journal-article","article-title":"The biomarker Ki-67: Promise, potential, and problems in breast cancer","volume":"31","author":"Gown","year":"2023","unstructured":"Gown, A. M. The biomarker Ki-67: Promise, potential, and problems in breast cancer. Appl Immunohistochem Mol Morphol. 31 (7), 478-484 (2023).","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"16","key":"ref65","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.7314\/APJCP.2015.16.16.6997","type":"journal-article","article-title":"Ki-67\/MIB-1 as a prognostic marker in cervical cancer - A systematic review with meta-analysis","volume":"16","author":"Piri","year":"2015","unstructured":"Piri, R. et al. Ki-67\/MIB-1 as a prognostic marker in cervical cancer - A systematic review with meta-analysis. Asian Pac J Cancer Prev. 16 (16), 6997-7002 (2015).","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"ref66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JTO.0000000000000092","type":"journal-article","article-title":"Ki-67 antigen in lung neuroendocrine tumors: Unraveling a role in clinical practice","volume":"9","author":"Pelosi","year":"2014","unstructured":"Pelosi, G. et al. Ki-67 antigen in lung neuroendocrine tumors: Unraveling a role in clinical practice. J Thorac Oncol. 9 (3), 273-284 (2014).","journal-title":"J Thorac Oncol"},{"issue":"9","key":"ref67","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1002\/cam4.1737","type":"journal-article","article-title":"A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor","volume":"7","author":"Li","year":"2018","unstructured":"Li, H. et al. A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor. Cancer Med. 7 (9), 4467-4474 (2018).","journal-title":"Cancer Med"},{"issue":"4","key":"ref68","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/bab.2233","type":"journal-article","article-title":"Caspase-3: Structure, function, and biotechnological aspects","volume":"69","author":"Asadi","year":"2022","unstructured":"Asadi, M. et al. Caspase-3: Structure, function, and biotechnological aspects. Biotechnol Appl Biochem. 69 (4), 1633-1645 (2022).","journal-title":"Biotechnol Appl Biochem"},{"issue":"6","key":"ref69","doi-asserted-by":"crossref","first-page":"e202201159","DOI":"10.1083\/jcb.202201159","type":"journal-article","article-title":"Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis","volume":"221","author":"Eskandari","year":"2022","unstructured":"Eskandari, E., Eaves, C. J. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol. 221 (6), e202201159 (2022).","journal-title":"J Cell Biol"},{"issue":"Pt B","key":"ref70","doi-asserted-by":"crossref","first-page":"111022","DOI":"10.1016\/j.intimp.2023.111022","type":"journal-article","article-title":"Caspase-3\/GSDME mediated pyroptosis: A potential pathway for sepsis","volume":"124","author":"Jiao","year":"2023","unstructured":"Jiao, C. et al. Caspase-3\/GSDME mediated pyroptosis: A potential pathway for sepsis. Int Immunopharmacol. 124 (Pt B), 111022 (2023).","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"ref71","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.31374","type":"journal-article","article-title":"Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells","volume":"143","author":"Zhou","year":"2018","unstructured":"Zhou, M. et al. Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells. Int J Cancer. 143 (4), 921-930 (2018).","journal-title":"Int J Cancer"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"113363","DOI":"10.1016\/j.jep.2020.113363","type":"journal-article","article-title":"Effect of weimaining on apoptosis and Caspase-3 expression in a breast cancer mouse model","volume":"264","author":"Ke","year":"2021","unstructured":"Ke, H. et al. Effect of weimaining on apoptosis and Caspase-3 expression in a breast cancer mouse model. J Ethnopharmacol. 264, 113363 (2021).","journal-title":"J Ethnopharmacol"},{"issue":"3-4","key":"ref73","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10495-023-01811-x","type":"journal-article","article-title":"The natural product dehydrocurvularin induces apoptosis of gastric cancer cells by activating PARP-1 and caspase-3","volume":"28","author":"Xu","year":"2023","unstructured":"Xu, H. et al. The natural product dehydrocurvularin induces apoptosis of gastric cancer cells by activating PARP-1 and caspase-3. Apoptosis. 28 (3-4), 525-538 (2023).","journal-title":"Apoptosis"},{"issue":"9","key":"ref74","first-page":"e1561","type":"journal-article","article-title":"Expression levels of Caspase-3 and gasdermin E and their involvement in the occurrence and prognosis of lung cancer","volume":"5","author":"Huang","year":"2022","unstructured":"Huang, Y. L. et al. Expression levels of Caspase-3 and gasdermin E and their involvement in the occurrence and prognosis of lung cancer. Cancer Rep (Hoboken). 5 (9), e1561 (2022).","journal-title":"Cancer Rep (Hoboken)"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/68023\/construction-lung-adenocarcinoma-xenograft-model-mice-evaluation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:27:56Z","timestamp":1792596476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68023\/construction-lung-adenocarcinoma-xenograft-model-mice-evaluation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":74,"journal-issue":{"issue":"218","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68023","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}